Table 8 Results of a 26-week Trial of Liraglutide Injection as Add-on to Metformin and Sulfonylurea in Adult Patients with Type 2 Diabetes Mellitus a Liraglutide Injection Compared to Exenatide, Both as Add-on to Metformin and/or Sulfonylurea Therapy In this 26-week, open-label trial, 464 adult patients with type 2 diabetes mellitus on a background of metformin monotherapy, sulfonylurea monotherapy or a combination of metformin and sulfonylurea were randomized to once daily liraglutide injection 1.8 mg or exenatide 10 mcg twice daily
Vitamin C and glutathione are the key ingredients in this revitalizing IV Therapy
Consistency matters more than the specific hour you choose
The best site is usually the one you can use correctly, consistently, and comfortably while following the medications Instructions for Use
Ready to feel better, look better, and live stronger
The activity of Foxo proteins is negatively regulated by the PI3K/Akt signaling pathway